SCHW
Schwab Charles CorpTrades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-07 | Craig Jonathan M. |
MD, Head of Investor Services |
Convert↓
Filing footnotes — Nonqualified Stock Option (right to buy) (Direct)
The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date. |
Nonqualified Stock Option (right to buy)
|
21,750 |
| 2026-07-07 | Craig Jonathan M. |
MD, Head of Investor Services |
Sell↓
Filing footnotes — Common Stock (Indirect)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2025. The transaction was executed in multiple trades at prices ranging from $102.00 to $102.10. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the transfer of shares and prices at which the transaction was effected. Reflects the contribution of the shares received upon exercise of the option to a revocable trust. |
Common Stock
(I)
|
21,750 |
| 2026-07-07 | Beatty Jonathan S |
MD, Head of Advisor Services |
Sell↓
Filing footnotes — Common Stock (Indirect)
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2026. This transaction was executed in multiple trades at prices ranging from $102.00 to $102.025. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
(I)
|
2,000 |
| 2026-07-07 | Craig Jonathan M. |
MD, Head of Investor Services |
Convert↑
Filing footnotes — Common Stock (Direct)
Reflects the contribution of the shares received upon exercise of the option to a revocable trust. |
Common Stock
|
21,750 |
| 2026-07-06 | Beatty Jonathan S |
MD, Head of Advisor Services |
Sell↓
Filing footnotes — Common Stock (Indirect)
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2026. This transaction was executed in multiple trades at prices ranging from $100.00 to $100.02. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. |
Common Stock
(I)
|
2,000 |
| 2026-07-02 | Beatty Jonathan S |
MD, Head of Advisor Services |
Sell↓
Filing footnotes — Common Stock (Indirect)
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2026. This transaction was executed in multiple trades at prices ranging from $97.00 to $97.045. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
(I)
|
2,000 |
| 2026-07-01 | HERRINGER FRANK C |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a right to receive one share of company stock. The RSUs were received pursuant to the Directors' Deferred Compensation Plan II (the "Plan") and are held in a rabbi trust for the benefit of the reporting person pursuant to the terms of the Plan. The RSUs were received in lieu of cash compensation otherwise payable as director fees. The RSU s are held in a rabbi trust for the benefit of the reporting person and are distributed to the reporting person when he leaves the Board of Directors. Includes 537.02 RSUs acquired through dividend reinvestment. |
Restricted Stock Units
|
457 |
| 2026-07-01 | Ruffel Charles A. |
Director |
Award↑
Filing footnotes — Nonqualified Stock Option (right to buy) (Direct)
The option was received in lieu of cash compensation otherwise payable as director fees. The option was received pursuant to the Directors' Deferred Compensation Plan II and vested immediately. |
Nonqualified Stock Option (right to buy)
|
1,280 |
| 2026-07-01 | Beatty Jonathan S |
MD, Head of Advisor Services |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld for taxes upon the settlement of restricted stock units granted to the reporting person on July 1, 2024. |
Common Stock
|
1,036 |
| 2026-07-01 | Brown Marianne Catherine |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a right to receive one share of company stock. The RSUs were received pursuant to the Directors' Deferred Compensation Plan II (the "Plan") and are held in a rabbi trust for the benefit of the reporting person pursuant to the terms of the Plan. The RSUs were received in lieu of cash compensation otherwise payable as director fees. The RSU s are held in a rabbi trust for the benefit of the reporting person and are distributed to the reporting person when she leaves the Board of Directors. Includes 27.69 RSUs acquired through dividend reinvestment. |
Restricted Stock Units
|
418 |
| 2026-07-01 | Ellis Stephen A |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a right to receive one share of company stock. The RSUs were received pursuant to the Directors' Deferred Compensation Plan II (the "Plan") and are held in a rabbi trust for the benefit of the reporting person pursuant to the terms of the Plan. The RSUs were received in lieu of cash compensation otherwise payable as director fees. The RSU s are held in a rabbi trust for the benefit of the reporting person and are distributed to the reporting person when he leaves the Board of Directors. Includes 45.48 RSUs acquired through dividend reinvestment. |
Restricted Stock Units
|
379 |
| 2026-06-23 | Ellis Stephen A |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Reflects the contribution of shares received upon exercise of the option to a trust. Reflects shares transferred from being held directly to a trust. |
Common Stock
|
2,258 |
| 2026-06-23 | Ellis Stephen A |
Director |
Convert↓
Filing footnotes — Nonqualified Stock Option (right to buy) (Direct)
The option was received pursuant to the Directors' Deferred Compensation Plan II and vested immediately. |
Nonqualified Stock Option (right to buy)
|
2,258 |
| 2026-06-03 | Verdeschi Michael D |
CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld for taxes upon the settlement of restricted stock units granted to the reporting person on June 3, 2024. |
Common Stock
|
6,519 |
| 2026-05-28 | Wurster Richard A |
Director, President & CEO |
Buy↑
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $84.04 to $84.51. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
21,959 |
| 2026-05-26 | Brown Marianne Catherine |
Director |
Award↑
Filing footnotes — Nonqualified Stock Option (right to buy) (Direct)
The option was granted under the company's 2022 Stock Incentive Plan and vests 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date |
Nonqualified Stock Option (right to buy)
|
3,977 |
| 2026-05-26 | Ellis Stephen A |
Director |
Award↑
Filing footnotes — Nonqualified Stock Option (right to buy) (Direct)
The option was granted under the company's 2022 Stock Incentive Plan and vests 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date |
Nonqualified Stock Option (right to buy)
|
3,977 |
| 2026-05-26 | SNEED PAULA A |
Director |
Award↑
Filing footnotes — Nonqualified Stock Option (right to buy) (Direct)
The option was granted under the company's 2022 Stock Incentive Plan and vests 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date |
Nonqualified Stock Option (right to buy)
|
3,977 |
| 2026-05-26 | Ellis Stephen A |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction constitutes a grant of restricted stock units, which were granted under the company's 2022 Stock Incentive Plan and vest 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date. Includes shares acquired through dividend reinvestment. |
Common Stock
|
1,602 |
| 2026-05-26 | ADAMS JOHN K JR |
Director |
Award↑
Filing footnotes — Nonqualified Stock Option (right to buy) (Direct)
The option was granted under the company's 2022 Stock Incentive Plan and vests 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date |
Nonqualified Stock Option (right to buy)
|
3,977 |
| 2026-05-26 | DODDS CHRISTOPHER V |
Director |
Award↑
Filing footnotes — Nonqualified Stock Option (right to buy) (Direct)
The option was granted under the company's 2022 Stock Incentive Plan and vests 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date |
Nonqualified Stock Option (right to buy)
|
3,977 |
| 2026-05-26 | HERRINGER FRANK C |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction constitutes a grant of restricted stock units, which were granted under the company's 2022 Stock Incentive Plan and vest 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date. |
Common Stock
|
1,602 |
| 2026-05-26 | SNEED PAULA A |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction constitutes a grant of restricted stock units, which were granted under the company's 2022 Stock Incentive Plan and vest 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date. |
Common Stock
|
1,602 |
| 2026-05-26 | SARIN ARUN |
Director |
Award↑
Filing footnotes — Nonqualified Stock Option (right to buy) (Direct)
The option was granted under the company's 2022 Stock Incentive Plan and vests 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date |
Nonqualified Stock Option (right to buy)
|
3,977 |
| 2026-05-26 | Dea Joan |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction constitutes a grant of restricted stock units, which were granted under the company's 2022 Stock Incentive Plan and vest 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date. |
Common Stock
|
1,602 |
| 2026-05-26 | Brown Marianne Catherine |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction constitutes a grant of restricted stock units, which were granted under the company's 2022 Stock Incentive Plan and vest 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date. |
Common Stock
|
1,602 |
| 2026-05-26 | DODDS CHRISTOPHER V |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction constitutes a grant of restricted stock units, which were granted under the company's 2022 Stock Incentive Plan and vest 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date. |
Common Stock
|
1,602 |
| 2026-05-26 | Ruffel Charles A. |
Director |
Award↑
Filing footnotes — Nonqualified Stock Option (right to buy) (Direct)
The option was granted under the company's 2022 Stock Incentive Plan and vests 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date |
Nonqualified Stock Option (right to buy)
|
3,977 |
| 2026-05-26 | ADAMS JOHN K JR |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction constitutes a grant of restricted stock units, which were granted under the company's 2022 Stock Incentive Plan and vest 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date. Includes 304.2606 shares acquired through dividend reinvestment. |
Common Stock
|
1,602 |
| 2026-05-26 | Ruffel Charles A. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction constitutes a grant of restricted stock units, which were granted under the company's 2022 Stock Incentive Plan and vest 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date. Includes 81.9458 shares acquired through dividend reinvestment. |
Common Stock
|
1,602 |
| 2026-05-26 | Dea Joan |
Director |
Award↑
Filing footnotes — Nonqualified Stock Option (right to buy) (Direct)
The option was granted under the company's 2022 Stock Incentive Plan and vests 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date |
Nonqualified Stock Option (right to buy)
|
3,977 |
| 2026-05-26 | Schwab-Pomerantz Carolyn |
Director |
Award↑
Filing footnotes — Nonqualified Stock Option (right to buy) (Direct)
The option was granted under the company's 2022 Stock Incentive Plan and vests 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date |
Nonqualified Stock Option (right to buy)
|
3,977 |
| 2026-05-26 | SARIN ARUN |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction constitutes a grant of restricted stock units, which were granted under the company's 2022 Stock Incentive Plan and vest 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date. |
Common Stock
|
1,602 |
| 2026-05-26 | HERRINGER FRANK C |
Director |
Award↑
Filing footnotes — Nonqualified Stock Option (right to buy) (Direct)
The option was granted under the company's 2022 Stock Incentive Plan and vests 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date |
Nonqualified Stock Option (right to buy)
|
3,977 |
| 2026-05-26 | Schwab-Pomerantz Carolyn |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction constitutes a grant of restricted stock units, which were granted under the company's 2022 Stock Incentive Plan and vest 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date. |
Common Stock
|
1,602 |
| 2026-05-22 | Schwab Charles R. |
10% Owner |
Gift↓
|
Common Stock
(I)
|
210,000 |
| 2026-05-21 | Dea Joan |
Director |
Gift↓
|
Common Stock
|
835 |
| 2026-05-19 | Schwab Charles R. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
This transaction was executed in multiple trades at prices ranging from $91.95 to $92.54. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
(I)
|
27,500 |
| 2026-05-18 | Schwab Charles R. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
This transaction was executed in multiple trades at prices ranging from $92.29 to $92.595. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
(I)
|
27,500 |
| 2026-05-15 | Schwab Charles R. |
10% Owner |
Gift↓
|
Common Stock
(I)
|
5,300 |
| 2026-05-13 | SARIN ARUN |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Reflects the contribution of the shares received upon exercise of the option to a revocable trust. |
Common Stock
|
7,866 |
| 2026-05-13 | SARIN ARUN |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
This transaction was executed in multiple trades at prices ranging from $91.14 to $91.18. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Reflects the contribution of the shares received upon exercise of the option to a revocable trust. |
Common Stock
(I)
|
2,500 |
| 2026-05-13 | SARIN ARUN |
Director |
Convert↓
Filing footnotes — Common Stock (Direct)
The option was granted under the company's 2013 Stock Incentive Plan and vested 25% on the first and second anniversary of the grant date and 50% on the third anniversary of the grant date. |
Common Stock
|
7,866 |
| 2026-05-06 | Schwab Charles R. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
This transaction was executed in multiple trades at prices ranging from $91.625 to $92.26. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
(I)
|
109,300 |
| 2026-05-05 | Schwab-Pomerantz Carolyn |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Reflects the contribution of the shares received upon exercise of the option to a revocable trust. |
Common Stock
|
9,910 |
| 2026-05-05 | Schwab-Pomerantz Carolyn |
Director |
Convert↓
Filing footnotes — Nonqualified Stock Option (right to buy) (Direct)
This option was granted under the company's 2013 Stock Incentive Plan and vested in four annual installments beginning on the first anniversary of the grant date. |
Nonqualified Stock Option (right to buy)
|
9,910 |
| 2026-05-05 | Schwab-Pomerantz Carolyn |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
This transaction was executed in multiple trades at prices ranging from $92.23 to $92.38. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. |
Common Stock
(I)
|
9,910 |
| 2026-05-04 | Schwab Charles R. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
This transaction was executed in multiple trades at prices ranging from $91.50 to $91.545. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
(I)
|
109,300 |
| 2026-05-01 | Schwab Charles R. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
This transaction was executed in multiple trades at prices ranging from $91.54 to $92.34. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Reflects a transfer of shares between trusts. |
Common Stock
(I)
|
55,000 |
| 2026-04-30 | Schwab Charles R. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
This transaction was executed in multiple trades at prices ranging from $91.61 to $92.12. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Reflects a transfer of shares between trusts. |
Common Stock
(I)
|
50,000 |